Hernandez James S
Mayo Medical Laboratories, Mayo Clinic, Rochester, Minn 55905, USA.
Arch Pathol Lab Med. 2003 Apr;127(4):440-5. doi: 10.5858/2003-127-0440-COLT.
To illustrate how laboratorians and pathologists must demonstrate accountability for efficiency (how well something is done), effectiveness (what is done), and cost-effectiveness (a proxy for value, in which value equals quality per cost).
A literature search was conducted, including documents in the National Library of Medicine.
The literature on cost-effectiveness of laboratory testing was reviewed.
The demand for proving the value of newer and more expensive medical technologies, including newer medical tests, will increase substantially. Payers, including Medicare, commercial insurers, and employers, will demand accountability and elimination of the abuse and misuse of ineffective testing strategies. Pathologists and laboratorians play a key role in guiding the most cost-effective use of testing strategies, including the judicious use of algorithms.
说明检验人员和病理学家必须如何对效率（工作完成得如何）、有效性（做了什么）和成本效益（价值的一种替代指标，其中价值等于质量除以成本）负责。
进行了文献检索，包括美国国立医学图书馆的文献。
对实验室检测成本效益的文献进行了综述。
证明包括新型医学检测在内的更新、更昂贵的医学技术的价值的需求将大幅增加。包括医疗保险、商业保险公司和雇主在内的支付方将要求负责并消除无效检测策略的滥用和误用。病理学家和检验人员在指导检测策略的最具成本效益的使用方面发挥关键作用，包括明智地使用算法。
